Literature DB >> 397957

Long-term effects of perinatal exposure to hormones on normal and neoplastic mammary growth in rodents: a review.

T Mori, H Nagasawa, H A Bern.   

Abstract

Exposure of mammals to hormones and drugs during pregnancy sometimes results in profound consequences in the offspring. In this review, the long-term effects of perinatal exposure to hormones on the mammary gland in female rodents at advanced ages are discussed as a model for possible human consequences of antenatal exposure to sex hormones. In general, antenatal hormone treatments may influence the development and growth of the mammary gland. Perinatal treatment with estrogen, androgen, progesterone, or even prolactin in some cases induces not only irreversible abnormality of mammary growth but also influences spontaneous and carcinogen-induced mammary tumorigenesis. Effects of neonatal hormone treatment on mammary tumorigenesis, which appear to be mainly due to the endogenous hormone imbalance produced, vary according to the time and period of the treatment and to the species and/or strain employed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 397957

Source DB:  PubMed          Journal:  J Environ Pathol Toxicol        ISSN: 0146-4779


  11 in total

Review 1.  Establishing a framework for the functional mammary gland: from endocrinology to morphology.

Authors:  Russell C Hovey; Josephine F Trott; Barbara K Vonderhaar
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-01       Impact factor: 2.673

Review 2.  Late insights into early origins of disease.

Authors:  Philippe Grandjean
Journal:  Basic Clin Pharmacol Toxicol       Date:  2008-02       Impact factor: 4.080

Review 3.  Roles of epidermal growth factor (EGF)-like factor in the ovulation process.

Authors:  Masayuki Shimada; Takashi Umehara; Yumi Hoshino
Journal:  Reprod Med Biol       Date:  2016-02-15

4.  Comparative effects of neonatal diethylstilbestrol on external genitalia development in adult males of two mouse strains with differential estrogen sensitivity.

Authors:  Phitsanu Mahawong; Adriane Sinclair; Yi Li; Bruce Schlomer; Esequiel Rodriguez; Max M Ferretti; Baomai Liu; Laurence S Baskin; Gerald R Cunha
Journal:  Differentiation       Date:  2014-10-16       Impact factor: 3.880

Review 5.  Female reproductive disorders: the roles of endocrine-disrupting compounds and developmental timing.

Authors:  D Andrew Crain; Sarah J Janssen; Thea M Edwards; Jerrold Heindel; Shuk-mei Ho; Patricia Hunt; Taisen Iguchi; Anders Juul; John A McLachlan; Jackie Schwartz; Niels Skakkebaek; Ana M Soto; Shanna Swan; Cheryl Walker; Teresa K Woodruff; Tracey J Woodruff; Linda C Giudice; Louis J Guillette
Journal:  Fertil Steril       Date:  2008-10       Impact factor: 7.329

6.  Stimulation by neonatal treatment with vitamin A of spontaneous mammary tumor development in GRS/A mice.

Authors:  H Nagasawa
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

Review 7.  Exposures to synthetic estrogens at different times during the life, and their effect on breast cancer risk.

Authors:  Leena Hilakivi-Clarke; Sonia de Assis; Anni Warri
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-02-08       Impact factor: 2.673

Review 8.  Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis.

Authors:  S Nandi; R C Guzman; J Yang
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

Review 9.  Environmental exposures and mammary gland development: state of the science, public health implications, and research recommendations.

Authors:  Ruthann A Rudel; Suzanne E Fenton; Janet M Ackerman; Susan Y Euling; Susan L Makris
Journal:  Environ Health Perspect       Date:  2011-06-22       Impact factor: 9.031

Review 10.  Effects of sex hormones on oncogene expression in the vagina and on development of sexual dimorphism of the pelvis and anococcygeus muscle in the mouse.

Authors:  T Iguchi; Y Fukazawa; H A Bern
Journal:  Environ Health Perspect       Date:  1995-10       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.